News

Rznomics aims for Korea's first clinical trial of RNA anticancer drug

  • 작성자
    관리자
  • 날짜
    2022-03-28

Rznomics' 'trans-splicing ribozyme' technology was introduced in the March 2022 issue of magazine.


Thank you for your support.


<Source>

Hankyung BioInsight